Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 114
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Phys Rev Lett ; 121(4): 041802, 2018 Jul 27.
Article in English | MEDLINE | ID: mdl-30095943

ABSTRACT

A novel mechanism to produce and detect light dark matter in experiments making use of GeV electrons (and positrons) impinging on a thick target (beam dump) is proposed. The positron-rich environment produced by the electromagnetic shower allows us to produce an A^{'} via nonresonant (e^{+}+e^{-}→γ+A^{'}) and resonant (e^{+}+e^{-}→A^{'}) annihilation on atomic electrons. The latter mechanism, for some selected kinematics, results in a larger sensitivity with respect to limits derived by the commonly used A^{'}-strahlung. This idea, applied to beam-dump experiments and active beam-dump experiments, pushes down the current limits by an order of magnitude.

2.
Nutr Neurosci ; 19(1): 43-6, 2016.
Article in English | MEDLINE | ID: mdl-25597866

ABSTRACT

The role of dysbiosis causing leaky gut with xenobiotic production and absorption is increasingly demonstrated in autism spectrum disorder (ASD) pathogenesis. Among xenobiotics, we focused on ochratoxin A (one of the major food contaminating mycotoxin), that in vitro and in vivo exerts a male-specific neurotoxicity probably via microRNA modulation of a specific target gene. Among possible targets, we focused on neuroligin4X. Interestingly, this gene carries some single nucleotide polymorphisms (SNPs) already correlated with the disease and with illegitimate microRNA binding sites and, being located on X-chromosome, could explain the male prevalence. In conclusion, we propose a possible gene-environment interaction triggering ASD explaining the epigenetic neurotoxic mechanism activated by ochratoxin A in genetically predisposed children. This mechanism offers a clue for male prevalence of the disease and may have an important impact on prevention and cure of ASD.


Subject(s)
Autism Spectrum Disorder/epidemiology , Autistic Disorder/epidemiology , Dysbiosis/epidemiology , Epigenesis, Genetic/drug effects , Ochratoxins/toxicity , Autism Spectrum Disorder/chemically induced , Autism Spectrum Disorder/genetics , Autistic Disorder/chemically induced , Autistic Disorder/genetics , Cell Adhesion Molecules, Neuronal/genetics , Cell Adhesion Molecules, Neuronal/metabolism , Child , Chromosomes, Human, X , Gene-Environment Interaction , Humans , Male , MicroRNAs/genetics , MicroRNAs/metabolism , Polymorphism, Single Nucleotide , Prevalence , Sex Factors
3.
Int J Mol Sci ; 17(10)2016 Oct 22.
Article in English | MEDLINE | ID: mdl-27782075

ABSTRACT

Since involved in synaptic transmission and located on X-chromosome, neuroligins 3 and 4X have been studied as good positional and functional candidate genes for autism spectrum disorder pathogenesis, although contradictory results have been reported. Here, we performed a case-control study to assess the association between noncoding genetic variants in NLGN3 and NLGN4X genes and autism, in an Italian cohort of 202 autistic children analyzed by high-resolution melting. The results were first compared with data from 379 European healthy controls (1000 Genomes Project) and then with those from 1061 Italian controls genotyped by Illumina single nucleotide polymorphism (SNP) array 1M-duo. Statistical evaluations were performed using Plink v1.07, with the Omnibus multiple loci approach. According to both the European and the Italian control groups, a 6-marker haplotype on NLGN4X (rs6638575(G), rs3810688(T), rs3810687(G), rs3810686(C), rs5916269(G), rs1882260(T)) was associated with autism (odd ratio = 3.58, p-value = 2.58 × 10-6 for the European controls; odds ratio = 2.42, p-value = 6.33 × 10-3 for the Italian controls). Furthermore, several haplotype blocks at 5-, 4-, 3-, and 2-, including the first 5, 4, 3, and 2 SNPs, respectively, showed a similar association with autism. We provide evidence that noncoding polymorphisms on NLGN4X may be associated to autism, suggesting the key role of NLGN4X in autism pathophysiology and in its male prevalence.


Subject(s)
Autism Spectrum Disorder/genetics , Cell Adhesion Molecules, Neuronal/genetics , Genetic Predisposition to Disease , Membrane Proteins/genetics , Nerve Tissue Proteins/genetics , Polymorphism, Single Nucleotide , Alleles , Autism Spectrum Disorder/diagnosis , Case-Control Studies , Child , Child, Preschool , Female , Gene Expression , Gene Frequency , Genetic Association Studies , Haplotypes , Humans , Italy , Male , Odds Ratio , Sex Factors
4.
J Eur Acad Dermatol Venereol ; 29(2): 383-386, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24404914

ABSTRACT

BACKGROUND: Skin adverse events associated with D-Penicillamine (DPA) are common and multi-faceted, although the presence of DPA or its metabolites has never been documented in the skin, because of inherent difficulties in determining its tissue levels. Thus, the association between DPA and DPA-related dermatoses has been only hypothesized on the basis of careful history, clinical observation and typical histopathological findings. OBJECTIVE: To detect DPA in biopsy specimens in a unique case of 25-year-late-onset elastosis perforans serpiginosa and pseudo-pseudoxanthoma elasticum associated with a history of long-term high dose DPA, by applying a recently described analytical method to assess the presence of DPA in skin. METHODS: We used a reliable analytical method based on high-performance liquid chromatography coupled with amperometric detection to look for the presence of DPA in skin biopsy specimens. RESULTS: A chromatographic peak corresponding to DPA was evidenced in some affected skin samples collected from the patient. CONCLUSION: We documented the effective presence and the persistence after 25 years of DPA in the skin of a woman affected by elastotic cutaneous change due to a long-term therapy with DPA. This report provides further evidence of the relationship between DPA deposit in affected skin and clinical manifestation.


Subject(s)
Chelating Agents/metabolism , Hepatolenticular Degeneration/drug therapy , Penicillamine/metabolism , Skin Diseases/chemically induced , Chelating Agents/therapeutic use , Female , Humans , Middle Aged , Penicillamine/adverse effects , Penicillamine/therapeutic use
5.
Annu Int Conf IEEE Eng Med Biol Soc ; 2021: 937-940, 2021 11.
Article in English | MEDLINE | ID: mdl-34891444

ABSTRACT

Human motion analysis is gaining increased importance in several fields, from movement assessment in rehabilitation to recreational applications such as virtual coaching. Among all the technologies involved in motion capture, Magneto-Inertial Measurements Units (MIMUs) is one of the most promising due to their small dimensions and low costs. Nevertheless, their usage is strongly limited by different error sources, among which magnetic disturbances, which are particularly problematic in indoor environments. Inertial Measurement Units (IMUs) could, thus, be considered as alternative solution. Indeed, relying exclusively on accelerometers and gyroscopes, they are insensitive to magnetic disturbances. Even if the literature has started to propose few algorithms that do not take into account magnetometer input, their application is limited to robotics and aviation. The aim of the present work is to introduce a magnetic-free quaternion based Extended Kalman filter for upper limb kinematic assessment in human motion (i.e., yoga). The algorithm was tested on five expert yoga trainers during the execution of the sun salutation sequence. Joint angle estimations were compared with the ones obtained from an optoelectronic reference system by evaluating the Mean Absolute Errors (MAEs) and Pearson's correlation coefficients. The achieved worst-case was 6.17°, while the best one was 2.65° for MAEs mean values. The accuracy of the algorithm was further confirmed by the high values of the Pearson's correlation coefficients (lowest mean value of 0.86).Clinical Relevance- The proposed work validated a magnetic free algorithm for kinematic reconstruction with inertial units. It could be used as a wearable solution to track human movements in indoor environments being insensitive to magnetic disturbances, and thus could be potentially used also for rehabilitation purposes.


Subject(s)
Yoga , Biomechanical Phenomena , Humans , Motion , Movement , Upper Extremity
6.
Neurosci Biobehav Rev ; 33(4): 601-10, 2009 Apr.
Article in English | MEDLINE | ID: mdl-17904221

ABSTRACT

UNLABELLED: Childhood neglect and poor child-parent relationships have been reported to increase substance use disorders susceptibility. Stressful environmental factors, including emotional neglect, could affect individual personality traits and mental health, possibly inducing stable changes in hypothalamic-pituitary-adrenal (HPA) axis and brain mono-amine function, in turn involved in addictive behavior vulnerability. Therefore, we decided to investigate homovanillic (HVA) and prolactin (PRL) plasma levels, as expression of possible changes in dopamine function, ACTH and cortisol plasma levels, as measures of HPA axis function, and concomitant psychiatric symptoms profile in abstinent cocaine addicts, in relationship to their childhood history of neglect and poor parental care perception. METHODS: Fifty abstinent cocaine dependent patients, and 44 normal controls, matched for age and sex, were submitted to a detailed psychiatric assessment (DSM IV criteria). All patients and controls completed the Symptoms Check List-90 (SCL-90) and the Buss Durkee Hostility Inventory (BDHI), to evaluate psychiatric symptoms frequency and aggressiveness levels. The Childhood Experience of Care and Abuse-Questionnaire (CECA-Q) and Parental Bonding Instrument (PBI) have been used to retrospectively investigate parent-child relationships. Blood samples were collected to determine HVA, PRL, ACTH and cortisol basal plasma levels. RESULTS: Cocaine addicted individuals in general showed significantly lower HVA, and higher PRL, ACTH and cortisol basal levels respect to controls. In particular, neuroendocrine changes characterized cocaine addicts with childhood history of neglect and low perception of parental care. Obsessive-compulsive, depression and aggressiveness symptoms have been found related to poor parenting, inversely associated to HVA levels and directly associated to PRL, ACTH and cortisol levels. CONCLUSIONS: These findings suggest the possibility that childhood experience of neglect and poor parent-child attachment may partially contribute to a complex neurobiological derangement including HPA axis and dopamine system dysfunctions, playing a crucial role in addictive and affective disorders susceptibility.


Subject(s)
Child Abuse , Cocaine-Related Disorders/psychology , Mental Disorders , Parenting/psychology , Adolescent , Adrenocorticotropic Hormone/blood , Adult , Child , Child, Preschool , Chromatography, High Pressure Liquid/methods , Electrochemistry , Female , Homovanillic Acid/blood , Humans , Hydrocortisone/blood , Male , Mental Disorders/blood , Mental Disorders/physiopathology , Mental Disorders/psychology , Personality , Prolactin/blood , Regression Analysis , Retrospective Studies , Surveys and Questionnaires , Young Adult
7.
Pediatr Med Chir ; 30(6): 281-9, 2008.
Article in Italian | MEDLINE | ID: mdl-19431950

ABSTRACT

The frequency of early-onset neonatal sepsis without prophylaxis is 1-5/1.000 live births. Since year '70 the most frequent causative microorganism is the group B Streptococcus (S. agalactiae, GBS), followed by Escherichia coli. The mortality rate is now reduced to 4% due to the improvement of neonatal intensive care. In the USA, the incidence of GBS early-onset neonatal sepsis has been markedly reduced by the application of the guidelines released by the Centers for Disease Control (CDC). This strategy, however, is not effective on occurrence of late-onset neonatal group B streptococcal disease. In Italy, the application of CDC guidelines is not customary, and different, often complex, protocols of obstetrical-neonatological integrated approach are applied. The frequency of infectious risk has made the GBS a paramount problem for the neonatologist, even for the legal responsibility issues resulting from the multiplicity of possible options. To reach the best level of protection of the newborn against early-onset GBS infection, the working group of providers of prenatal, obstetric, and neonatal care of the functional area of Cuneo issued an integrated protocol, in order to perform the GBS screening with the optimal culture method suggested by CDC guidelines in the highest possible number of pregnant women, and to standardize the obstetrical and neonatal management.


Subject(s)
Pregnancy Complications, Infectious/diagnosis , Streptococcal Infections/prevention & control , Streptococcus agalactiae , Adult , Age Factors , Algorithms , Anti-Bacterial Agents/pharmacology , Clindamycin/pharmacology , Clinical Protocols , Erythromycin/pharmacology , Female , Humans , Infant, Newborn , Intensive Care, Neonatal , Italy , Microbial Sensitivity Tests , Practice Guidelines as Topic , Pregnancy , Prevalence , Rectum/microbiology , Risk Factors , Streptococcal Infections/diagnosis , Streptococcal Infections/epidemiology , Streptococcal Infections/mortality , Streptococcal Infections/transmission , Streptococcus agalactiae/drug effects , Streptococcus agalactiae/isolation & purification , United States , Vagina/microbiology
8.
Transplant Proc ; 39(2): 505-8, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17362768

ABSTRACT

There is only limited information about recipient risk factors for graft survival in living- donor kidney transplantation. This study aimed to investigate prognostic factors and their impact on living-related and unrelated renal transplant recipients. From October 2000 until October 2004, 81 adult living-related renal transplantations were performed at our institution. Using multivariate analysis, the association of the following variables with kidney graft outcome was studied: ages of donors and recipients, gender and body mass index, cold and warm ischemia, HLA mismatches, identity and compatibility of blood group, duration of dialysis, cytomegalovirus (CMV) status, recipient original disease, surgical and general complications, and status of retransplantation. Multivariate analysis revealed significant reduction of graft function and graft survival in recipients with retransplantation, more than 4 mismatches, and a high body mass index. Thus, living-donor kidney transplantation can be regarded as a safe and standardized operation relating to surgical technique, but further consideration of the recipient body mass index and the number of mismatches are recommended during the preparation for transplantation.


Subject(s)
Kidney Transplantation/adverse effects , Kidney Transplantation/physiology , Living Donors , Adult , Blood Group Incompatibility/epidemiology , Female , Histocompatibility Testing , Humans , Kidney Transplantation/immunology , Male , Middle Aged , Postoperative Complications/epidemiology , Reoperation/statistics & numerical data , Risk Assessment , Treatment Failure , Treatment Outcome
9.
Curr Drug Metab ; 7(2): 127-33, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16472103

ABSTRACT

A review with 103 references. Fluoxetine is the parent drug of the SSRI (selective serotonin reuptake inhibitor) antidepressant class, and is still one of the most highly used drugs of this class world-wide. Fluoxetine now has largely (albeit not completely) substituted older and less safe drugs such as tricyclic antidepressants. Different cytochrome P450 isoforms are involved in the metabolism of fluoxetine, however, the main active metabolite, norfluoxetine, is produced by the CYP2D6 action in the human liver. In this paper, the main metabolic characteristics of fluoxetine will be reviewed, with particular attention paid to the role of cytochrome isozymes. The pharmacological interactions of the drug will be overviewed, especially those concerning other drugs used in psychiatric clinics, such as antipsychotics and antidepressants and the relationships between pharmacological interactions and cytochrome activity will be discussed. Recently, much attention has been drawn to the therapeutic drug monitoring (TDM) of fluoxetine, and in particular to the analysis of fluoxetine enantiomers for which enantiomeric separations and enantioselective metabolism will also briefly be mentioned.


Subject(s)
Cytochrome P-450 Enzyme System/metabolism , Fluoxetine/pharmacology , Fluoxetine/pharmacokinetics , Selective Serotonin Reuptake Inhibitors/pharmacology , Selective Serotonin Reuptake Inhibitors/pharmacokinetics , Animals , Drug Interactions , Female , Humans , Lactation/physiology , Pregnancy , Stereoisomerism
10.
J Pharm Biomed Anal ; 42(1): 32-8, 2006 Sep 11.
Article in English | MEDLINE | ID: mdl-16378705

ABSTRACT

A new fast capillary electrophoretic method has been developed for the analysis of the glycopeptide antibiotic vancomycin in formulations. An electrophoretic run is completed within 3.0 min; fused silica capillaries (100 microm i.d., 8.5 cm effective length and 48.5 cm total length) and a background electrolyte consisting of 12.5 mM, pH 2.5 phosphate buffer are used. The applied voltage is -20.0 kV; samples are injected by pressure (30 mbar x 3 s) at the anodic end of the capillary. The method was successfully applied to innovative controlled release microparticles consisting of a coated albumin core containing vancomycin. A simple procedure has been developed to obtain complete vancomycin extraction from microparticles using a 5% (w/v) sodium dodecyl sulphate aqueous solution. The method has been validated in terms of linearity, precision and accuracy. Good linearity was found in the 0.25-5.00 microg/mL range. Satisfactory precision was obtained, with relative standard deviation values always lower than 3.9%; accuracy was satisfactory, with recovery values between 97.8 and 102.2%. The method is also suitable for vancomycin determination in commercial capsules.


Subject(s)
Anti-Bacterial Agents/analysis , Electrophoresis, Capillary/methods , Vancomycin/analysis , Capsules , Chemistry, Pharmaceutical , Hydrogen-Ion Concentration
11.
J Pharm Biomed Anal ; 42(1): 107-12, 2006 Sep 11.
Article in English | MEDLINE | ID: mdl-16406455

ABSTRACT

A sensitive high-performance liquid chromatographic method has been developed for the determination of homovanillic acid (HVA), the main metabolite of dopamine, in human plasma. Analyses were carried out on a reversed-phase column (C8, 250 mm x 4.6 mm i.d., 5 microm) using a mobile phase composed of 10% methanol and 90% aqueous citrate buffer, containing octanesulfonic acid and EDTA at pH 4.8. Coulometric detection was used, setting the guard cell at +0.100 V, the first analytical cell at -0.200 V and the second analytical cell at +0.500 V. A careful solid-phase extraction procedure, based on strong anion exchange (SAX) cartridges (100 mg, 1 mL), was implemented for the pre-treatment of plasma samples. Extraction yield was satisfactory, being the mean value 98.0%. The calibration curve was linear over the concentration range of 0.2-25.0 ng mL(-1) of homovanillic acid. The limit of quantitation (LOQ) was 0.2 ng mL(-1) and the limit of detection (LOD) was 0.1 ng mL(-1). The method was successfully applied to plasma samples from former alcohol, cocaine and heroin addicts. Results were satisfactory in terms of precision and accuracy. Hence, the method is suitable for the determination of homovanillic acid in human plasma.


Subject(s)
Chromatography, High Pressure Liquid/methods , Homovanillic Acid/blood , Calibration , Electrochemistry , Humans , Sensitivity and Specificity
12.
Seizure ; 15(2): 86-92, 2006 Mar.
Article in English | MEDLINE | ID: mdl-16406695

ABSTRACT

OBJECTIVE: To investigate the relevance of serum topiramate (TPM) levels (SL) monitoring in the clinical management of epileptic patients. METHODS: Twenty-seven patients with different epileptic syndromes on TPM therapy were studied. TPM was used as add-on in 26 patients, only in one as monotherapy de novo; one case changed from TPM as add-on to TPM monotherapy. The mean follow-up time was 11 months. TPM SL were measured by fluorescence polarization immunoassay. RESULTS: We analyzed the TPM SL in 43 samples from 27 patients. Mean TPM dose was 3.9mg/kg, mean TPM SL 13.43mumol/l. The mean level to dose ratio (LDR) was 3.63mumol/l/mg/kg. Four patients became seizure-free, all with TPM dosages lower than the mean. Eleven patients had at least 50% seizure reduction. The comedication with enzyme-inducing AED significantly reduced TPM SL and LDR. On the other hand, the influence of valproic acid (VPA) on TPM LDR was not univocal. Indeed, patients younger than 15 years showed SL values lower than the adults did, although not significant. CONCLUSION: We could not detect a direct relationship between high TPM SL and efficacy neither between high TPM SL and tolerability. However, the data we collected seem to favour the hypothesis that high TPM dosage and SL might be associated to a greater probability to reduce seizure severity.


Subject(s)
Anticonvulsants/administration & dosage , Epilepsy/drug therapy , Fructose/analogs & derivatives , Adolescent , Adult , Anticonvulsants/blood , Anticonvulsants/pharmacokinetics , Child , Child, Preschool , Dose-Response Relationship, Drug , Drug Therapy, Combination , Epilepsy/blood , Female , Fructose/administration & dosage , Fructose/blood , Fructose/pharmacokinetics , Humans , Infant , Male , Middle Aged , Prospective Studies , Regression Analysis , Topiramate
13.
J Ethnopharmacol ; 104(1-2): 113-8, 2006 Mar 08.
Article in English | MEDLINE | ID: mdl-16226416

ABSTRACT

Emblica officinalis Gaertn. is one of the most important plants of Ayurved, the traditional Indian medicine. In this ancient medicine, the fruit of Emblica officinalis is processed according to a method named "Svaras Bhavana", whereby the therapeutic potential of the plant is enhanced by treating the main herb with its own juice. For many years, the activity of the fruits was attributed to the high content of ascorbic acid; however, this has recently been questioned. The aim of the paper is to clarify this matter. A reliable and feasible HPLC method with diode array detection has been developed for the determination of ascorbic acid in Emblica fruit and particularly in Emblica fruit processed according to the Ayurvedic method. The antioxidant effects have also been evaluated in comparison to the real levels of Vitamin C by different antioxidant tests. The data obtained show that the Emblica fruit contains ascorbic acid (0.4%, w/w), and that the Ayurvedic method of processing increases the healthy characteristics of the fruit thanks to a higher antioxidant activity and a higher content of ascorbic acid (1.28%, w/w). It has also been found that Vitamin C accounts for approximately 45-70% of the antioxidant activity.


Subject(s)
Antioxidants/isolation & purification , Ascorbic Acid/isolation & purification , Fruit , Medicine, Ayurvedic , Phyllanthus emblica , Antioxidants/analysis , Ascorbic Acid/analysis , Plant Extracts/analysis , Plant Extracts/isolation & purification
14.
Biochim Biophys Acta ; 445(1): 223-33, 1976 Aug 12.
Article in English | MEDLINE | ID: mdl-182275

ABSTRACT

1. Rat skeletal muscle AMP deaminase (AMP aminohydrolase, EC3.5.4.6) can be inactivated by incubation with the periodate-oxidized analogue of the enzyme inhibitor GTP. 2. Nucleoside triphosphates and KCl at high concentrations protect against inactivation, while ADP has no effect. 3. The inactivation can be reversed by the addition of GTP and amino acids and made irreversible by reduction with NaBH4. This indicates that, in the binding of the oxidized GTP to the enzyme, a Schiff base is formed between the aldehyde groups of the inhibitor and amino groups of the enzyme. 4. The kinetic properties of the reduced (oxidized GTP)-AMP deaminase derivative indicate that the loss of activity results from an increase in Km while no appreciable change in V is observed; consequently, the enzyme shows positive homotropic cooperativity even in the presence of optimal KCl concentration. 5. Since the treated enzyme shows kinetic properties similar to those of the native enzyme in the presence of GTP, and since the loss of sensitivity to GTP is directly proportional to the degree of inactivation, it is concluded that the oxidized GTP specifically modifies the binding sites for GTP. 6. Binding of the radioactive oxidized GTP shows that two binding sites for this reagent exist in the AMP deaminase molecule.


Subject(s)
AMP Deaminase/antagonists & inhibitors , Guanosine Triphosphate/pharmacology , Nucleotide Deaminases/antagonists & inhibitors , Adenosine Diphosphate/pharmacology , Animals , Binding Sites , Borohydrides , Kinetics , Muscles/enzymology , Oxidation-Reduction , Periodic Acid , Potassium Chloride/pharmacology , Protein Binding , Rats , Valine/pharmacology
15.
Biochim Biophys Acta ; 742(3): 623-9, 1983 Feb 15.
Article in English | MEDLINE | ID: mdl-6838893

ABSTRACT

Rabbit skeletal muscle AMP deaminase (AMP aminohydrolase, EC 3.5.4.6) at low temperature and pH value above 7 undergoes inactivation, with a half-time of the order of several minutes. The loss of activity becomes more extensive at lower enzyme concentrations and higher pH values. It is reversible, since cold-inactivated AMP deaminase can be reactivated by raising the temperature, but not by lowering the pH, of the incubation mixture. The residual activity at the end of the inactivation process at various temperatures, reflecting the equilibrium between active and inactive forms of the enzyme, has been studied as a function of pH to determine the apparent pK and heat of ionization of the process. A general mechanism of reversible inactivation of AMP deaminase is postulated which assumes that deprotonation of the enzyme is followed by isomerization to a form which at low temperature slowly dissociates into the less-active subunits. Cold-inactivated AMP deaminase no longer shows the pH-dependent sigmoidal behaviour of the native enzyme, but regains this property along with the reactivation process. This suggests that allosteric kinetics at basic pH are probably produced by the same isomerization process which is involved in the mechanism for cold lability of the enzyme.


Subject(s)
AMP Deaminase/metabolism , Muscles/enzymology , Nucleotide Deaminases/metabolism , Animals , Cold Temperature , Hydrogen-Ion Concentration , Kinetics , Macromolecular Substances , Rabbits , Structure-Activity Relationship
16.
Biochim Biophys Acta ; 566(2): 353-61, 1979 Feb 09.
Article in English | MEDLINE | ID: mdl-570422

ABSTRACT

1. Rat skeletal muscle AMP deaminase (AMP aminohydrolase, EC 3.5.4.6) at optimal KCl concentrations shows a biphasic response to increasing levels of the allosteric inhibitor ATP. 2. Up to 10 micrometer, ATP appears to convert the enzyme to a form exhibiting sigmoidal kinetics while at higher concentrations its inhibitory effect is manifested by an alteration of AMP binding to AMP deaminase indicative of negative homotropic cooperativity at about 50% saturation. 3. AMP deaminase is inactivated by incubation with the periodate oxidation product of ATP. The (oxidized ATP)--AMP deaminase complex stabilized by NaBH4 reduction shows kinetic properties similar to those of the native enzyme in the presence of high ATP concentrations. 4. A plausible explanation of the observed cooperativity is that ATP induces different conformational state of AMP deaminase subunits, causing the substrate to follow a sequential mechanism of binding to enzyme. 5. Binding of the radioactive oxidized ATP shows that 3.2 mol of this reagent bind per mol AMP deaminase.


Subject(s)
AMP Deaminase/antagonists & inhibitors , Adenosine Triphosphate/pharmacology , Muscles/enzymology , Nucleotide Deaminases/antagonists & inhibitors , Animals , Binding Sites , Dose-Response Relationship, Drug , Kinetics , Macromolecular Substances , Oxidation-Reduction , Potassium Chloride/pharmacology , Protein Binding , Protein Conformation , Rats
17.
Biochim Biophys Acta ; 827(1): 93-100, 1985 Jan 21.
Article in English | MEDLINE | ID: mdl-3967031

ABSTRACT

Limited proteolysis of rabbit skeletal muscle AMP deaminase (AMP aminohydrolase, EC 3.5.4.6) with trypsin results in conversion of the enzyme to a form which is no longer inhibited by ATP and exhibits hyperbolic kinetics even at low K+ concentration and in the absence of ADP. The interaction with troponin T from white skeletal muscle or with the phosphorylated 42-residue N-terminal peptide of troponin T restores in the trypsin-treated AMP deaminase the sensitivity to adenine nucleotides and increases the KA for K+ activation of the enzyme from 1 mM to 12 mM, this effect being diametrically opposite to that exerted by limited proteolysis on the native enzyme. Treatment of the N-terminal peptide of troponin T with alkaline phosphatase abolishes the modulating properties of the peptide, suggesting that phosphorylation-dephosphorylation processes may be involved in the regulation of the enzyme.


Subject(s)
AMP Deaminase/metabolism , Muscles/enzymology , Nucleotide Deaminases/metabolism , Troponin/metabolism , Alkaline Phosphatase , Kinetics , Peptide Fragments , Troponin T , Trypsin
18.
Biochim Biophys Acta ; 1544(1-2): 123-32, 2001 Jan 12.
Article in English | MEDLINE | ID: mdl-11341922

ABSTRACT

Reaction of rabbit skeletal muscle AMP deaminase with a low molar excess of trinitrobenzene sulfonic acid (TNBS) results in conversion of the enzyme into a species with about six trinitrophenylated lysine residues per molecule which no longer manifests positive homotropic cooperativity at pH 7.1 or at the optimal pH value of 6.5 in the presence of low K+ concentrations. Substitution of the reactive thiol groups with 5,5'-dithiobis-(2-nitrobenzoic acid) does not protect the enzyme from the TNBS-induced changes of the catalytic properties, indicating that cysteine residues modification is not at the basis of the effects of TNBS treatment on AMP deaminase and strongly suggesting the obligatory participation of lysine residues to the constitution of a regulatory anionic site to which AMP must bind to stimulate the enzyme at alkaline pH. The TNBS-treated enzyme is also completely desensitized to inhibition by ATP, but not to inhibition by GTP and stimulation by ADP. This observation suggests a connection between the operation of the hypothesized anionic activating site, responsible for positive homotropic cooperativity, and the inhibition exerted by anionic compounds that compete for the same site, among them the most efficient metabolite being probably ATP.


Subject(s)
AMP Deaminase/metabolism , Lysine/metabolism , Muscle, Skeletal/enzymology , AMP Deaminase/chemistry , Animals , Catalysis , Hydrogen-Ion Concentration , Rabbits , Trinitrobenzenesulfonic Acid/chemistry
19.
Biochim Biophys Acta ; 1209(1): 123-9, 1994 Nov 16.
Article in English | MEDLINE | ID: mdl-7947974

ABSTRACT

Rabbit skeletal muscle AMP deaminase was submitted to limited proteolysis by trypsin that converts the native 80 kDa enzyme subunit to a stable product of approx. 70 kDa, which, in contrast to the native enzyme, is not sensitive to regulation by ATP at pH 6.5. Tryptic peptide mapping indicates that proteolysis is confined to the N-terminal region of the molecule, identifying in this region of AMP deaminase a non-catalytic, 95 residue regulatory domain that stabilises the binding of ATP to a distant site in the molecule. Protein sequence analysis reveals a marked degree of divergence between rat and rabbit skeletal muscle AMP deaminases in the regions containing residues 7-12 and 51-52, giving molecular basis to the hypothesis of the existence of isoenzymes of AMP deaminase in the mature skeletal muscle of the mammals.


Subject(s)
AMP Deaminase/chemistry , Muscle, Skeletal/enzymology , Adenosine Triphosphate/chemistry , Amino Acid Sequence , Animals , Binding Sites , Electrophoresis, Polyacrylamide Gel , Humans , Molecular Sequence Data , Peptide Fragments/chemistry , Rabbits , Rats , Species Specificity , Trypsin
20.
Biochim Biophys Acta ; 1702(2): 191-8, 2004 Nov 01.
Article in English | MEDLINE | ID: mdl-15488771

ABSTRACT

On storage at 4 degrees C, rabbit skeletal muscle AMP deaminase undergoes limited proteolysis with the conversion of the native 85-kDa enzyme subunit to a 75-kDa core that is resistant to further proteolysis. Further studies have shown that limited proteolysis of AMP deaminase with trypsin, removing the 95-residue N-terminal fragment, converts the native enzyme to a species that exhibits hyperbolic kinetics even at low K+ concentration. The results of this report show that a 21-residue synthetic peptide, when incubated with the purified enzyme, is cleaved with a specificity identical to that reported for ubiquitous calpains. In addition, the cleavage of a specific fluorogenic peptide substrate by rabbit m-calpain is inhibited by a synthetic peptide that corresponds to residues 10-17 of rabbit skeletal muscle AMP deaminase; this peptide contains a sequence (K-E-L-D-D-A) that is present in the fourth subdomain A of rabbit calpastatin, suggesting that the N-terminus of AMP deaminase shares with calpastatin a regulatory sequence that might exert a protective role against the fragmentation-induced activation of AMP deaminase. These observations suggest that a calpain-like proteinase present in muscle removes from AMP deaminase a domain that holds the enzyme in an inactive conformation and which also contains a regulatory region that protects against unregulated proteolysis. We conclude that proteolysis of AMP deaminase is the basis of the large ammonia accumulation that occurs in skeletal muscle subjected to strong tetanic contraction or passing into rigor mortis.


Subject(s)
AMP Deaminase/chemistry , AMP Deaminase/metabolism , Calpain/metabolism , Muscle, Skeletal/enzymology , AMP Deaminase/genetics , Animals , Calpain/antagonists & inhibitors , Enzyme Activation , Humans , Peptides/genetics , Peptides/metabolism , Rabbits
SELECTION OF CITATIONS
SEARCH DETAIL